Pharmacologic Management of Acute Attacks of Migraine and Prevention of Migraine Headache
Ann Int Med 137:840-849, Snow,V.,et al, 2002
Late Secondary Ischemic Injury in Patients Receiving Intraarterial Thrombolysis
Ann Neurol 52:698-703,695, Kidwell,C.S.,et al, 2002
Lack of Clinical Significance of Early Ischemic Changes on Computed Tomography in Acute Stroke
JAMA 286:2830-2838, Patel,S.C.,et al, 2001
Intravenous Tissue-Type Plasminogen Activator Therapy for Ischemic Stroke
Arch Neurol 58:2009-2013, Grotta,J.C.,et al, 2001
Acute Stroke Care in Non-urban Emergency Departments
Neurol 57:2006-2012, Burgin,W.S.,et al, 2001
Thrombolysis in Patients with Transient Neurologic Deficits
Neurol 57:2125-2128, Lyden,P.,et al, 2001
[123I]Beta-CIT SPECT Imaging Assessment of the Rate of Parkinson's Disease Progression
Neurol 57:2089-2094, Marek,K.,et al, 2001
Individual State Driving Restrictions for People With Epilepsy in the US
Neurol 57:1780-1785,1749, Krauss,G.L.,et al, 2001
A Messy Necessary End
Neurol 56:148-152, Goldblatt,D., 2001
Chorea and Antiphospholipid Antibodies: Treatment with Methotrexate
Neurol 56:137-138, Paus,S.,et al, 2001
Primary Prevention of Ischemic Stroke
Stroke 32:280-299, Goldstein,L.B.,et al, 2001
Protocol Violations in Community-Based rTPA Stroke Treatment Are Associated with Symptomatic Intracerebral Hemorrhage
Stroke 32:12-16, Lopez-Yunez,A.M.,et al, 2001
Functional Correlates of Pallidal Stimulation for Parkinson's Disease
Ann Neurol 49:155-164,142, Fukuda,M.,et al, 2001
Risk Factors for Sever Hemorrhagic Transformation in Ischemic Stroke Patients Treated with Recombinant Tissue Plasminogen Activator
Stroke 32:438-441, Larrue,V.,et al, 2001
Diffusion-weighted MR Imaging in a Case of Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Strokelike Episodes
AJNR 22:269-272, Yonemura,K.,et al, 2001
Effect of Donepezil on Brain Acetylcholineserase Activity in Patients with AD Measured by PET
Neurol 56:408-410, Shinotoh,H.,et al, 2001
Deterioration Following Improvement with tPA Therapy: Carotid Thrombosis and Reocclusion
Neurol 56:568-570, Burgin,W.S. &Alexandrov,A.V., 2001
Radiography of the Lumbar Spine in Primary Care Patients with Low Back Pain: Randomised Controlled Trial
BMJ 322:400-405, Kendrick,D.,et al, 2001
Transplantation of Embryonic Dopamine Neurons for Severe Parkinson's Disease
NEJM 344:710-719,763, Freed,C.R.,et al, 2001
Phenylpropanolamine and Hemorrhagic Stroke
NEJM 344:1094-1095, Ernst,M.E.,et al, 2001
Early Detection of Dementia: Mild Cognitive Impairment (an Evidence-based Review)
Neurol 56:1133-1142, 1131, Petersen,R.C.,et al, 2001
Carotid Endarterectomy
The Neurologist 7:135-136, Stewart-Amidei,C., 2001
Most Commonly Asked Questions About Intra-arterial Thrombolysis
The Neurologist 7:127-131, Wechsler,L.R., 2001
Practice Parameter: Diagnosis of Dementia (an Evidence-Based Review)
Neurol 56:1143-1153, Knopman,D.S.,et al, 2001
Practice Parameter: Management of Dementia (an Evidence-Based Review)
Neurol 56:1154-1166, Doody,R.S.,et al, 2001
Intraspinal Steroids: History, Efficacy, Accidentality, and Controversy with Review of United States Food and Drug Administration Reports
JNNP 70:433-443, Nelson,D.A. & Landau,W.M., 2001
Community Use of Intravenous Tissue Plasminogen Activator for Acute Stroke
Stroke 32:861-865, Katzan,I.L.,et al, 2001
Acute Stroke Management in the Local General Hospital
Stroke 32:866-870, Handschu,R.,et al, 2001
Why Are Stroke Patients Excluded from TPA Therapy?
Neurol 56:1015-1020, Barber,P.A.,et al, 2001
Malpractice Claims: Outcome Evidence to Guide Neurologic Education?
Neurol 56:1099-1100,991, Glick,T.H., 2001
Cerebral Sinus Thrombosis with Tamoxifen
Neurol 56:1113-1114, Finelli,P.F. & Schauer,P.K., 2001
Statins for Stroke Prevention?
Lancet 357:1548-1549, Sandercock,P., 2001
The Frequency of Carpal Tunnel Syndrome in Computer Users at a Medical Facility
Neurol 56:1568-1570, Clarke Stevens,J.,et al, 2001
Safety of Intra-Arterial Thrombolysis in the Postoperative Period
Stroke 32:1365-1369, Chalela,J.A.,et al, 2001
Recommended Diagnostic Criteria for Multiple Sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis
Ann Neurol 50:121-127, McDonald,W.I.,et al, 2001
Subclinical Dopaminergic Dysfunction in Asymptomatic Parkinson's Disease Patients' Relatives with a Decreased Sense of Smell
Ann Neurol 50:34-41, Berendse,H.W.,et al, 2001
A Language Barrier, Abdominal Pain, and Double Vision
Lancet 357:2022, Basnyat,B.,et al, 2001
The Late Whiplash Syndrome: A Biopsychosocial Approach
JNNP 70:722-726, Ferrari,R. &Schrader,H., 2001
F-Fluorodeoxyglucose Positron Emission Tomography and MR Imaging Findings in Rasumussen Encephalitis
AJNR 22:1291-1299, Fiorella,D.J.,et al, 2001
Comtan (Entacapone) The Treatment of Parkinson's Disease, Questions & Answers
APDA Ed Suppl #15, Watts,R.L., 2001
Intra-Arterial Thrombolysis
Neurol 57:S58-S60, Saver,J.L., 2001
Practice Patterns of Neurologists Regarding Bone and Mineral Effefcts of Antiepileptic Drug Therapy
Arch Neurol 58:1369-1374,1352, Valmadrid,C.,et al, 2001
Parenchymal Hyperdensity on Computed tomography after Intra-Arterial Reperfusion Therapy for Acugte Middle Cerebral Artery Occlusion,Incidence and Clinical Significance
Stroke 32:2042-2048, Nakano,S.,et al, 2001
Tourette's Syndrome
NEJM 345:1184-1192, Jankovic,J., 2001
Extracranial Carotid Stenosis
NEJM 345:1113-1118, Sacco,R., 2001
Cerebral Hemorrhage After Intra-arterial Thrombolysis for Ischemic Stroke
Neurol 57:1603-1610, Kase,C.S.,et al, 2001
Systematic Review of Immunomodulatory Drugs for the Treatment of People with Multiple Sclerosis: Is There Good Quality Evidence on Effectiveness and Cost?
JNNP 70:574-579, Bryan,J.,et al, 2001
Evidence Based Medicine: Concerns of a Clinical Neurologist
JNNP 71:569-576, Caplan,L.R., 2001
The Effect of Brain Atrophy on Cerebral Hypometabolism in the Visual Variant of Alzheimer Disease
Arch Neurol 58:480-486, Bokde,A.L.W.,et al, 2001
The Expanding Spectrum of Herpesvirus Infections of the Nervous System
Brain Pathology 11:440-451, Kleinschmidt-DeMasters,B.K. &Gilden,D.H., 2001